Cyclacel (NASDAQ:CYCC) is developing several innovative therapies that target various phases of cell cycle control for the treatment of solid tumor and blood-borne cancers, such as leukemia. “In cancer patients certain innate mechanisms which control proliferation and induce cancer cells to commit suicide, via apoptosis, are malfunctioning. This enables cancer cells to develop resistance to […]

Clinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to fight cancer. Catherine Longworth spoke to CEO Mondher Mahjoubi to find out the science behind this next generation of immunotherapies.  Founded in 1999, Marseille-based company Innate Pharma is on a mission to develop immunotherapies that take advantage […]

It’s been 18 years since a new drug has been approved to treat Alzheimer’s disease, but one such medication is moving toward an FDA decision. That drug is part of an ongoing clinical trial. An FDA advisory panel says, so far, there’s not enough wide-scale evidence it is effective for the general population. In the […]